Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$67.72 USD
-0.14 (-0.21%)
Updated May 17, 2024 04:00 PM ET
After-Market: $67.75 +0.03 (0.04%) 7:58 PM ET
5-Strong Sell of 5 5
B Value C Growth C Momentum C VGM
Brokerage Reports
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 481 - 500 ( 523 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Q3:10 Earnings Preview: Raising EPS due to Change in Share Buyback Schedule.
Provider: WEDBUSH SECURITIES INC.
Analyst: XU Y
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Lower than expected performance by HIV franchise remains a serious concern.
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
2010 AASLD Abstract Titles Review - Second Wave Including Late-Breakers
Provider: WEDBUSH SECURITIES INC.
Analyst: XU Y
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology / Biopharmaceuticals -2010 AASLD Abstract Titles Review - First Wave Without Late Breakers
Provider: WEDBUSH SECURITIES INC.
Analyst: XU Y
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Can Btripla Deliver the Promise - AIDS Conf Abstract Review
Provider: WEDBUSH SECURITIES INC.
Analyst: XU Y
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Btripla vs. Atripla and Q2 Earnings Next; Lowering PT to $40.
Provider: WEDBUSH SECURITIES INC.